Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brightlands Venture Partners is a Netherlands-based venture capital fund manager that invests in science-driven startups addressing challenges in health, agrifood, and renewable chemistry. Within healthcare, the firm backs early-stage companies in areas such as regenerative medicine, biomedical materials, diagnostics, analytics, drug delivery, formulation, and related deep-tech health innovations. The firm operates multiple funds linked to the Brightlands ecosystem and invests primarily from seed to Series A, with a stated focus on European companies. Brightlands Venture Partners is not a drug developer itself; rather, it provides capital and strategic support to portfolio companies building health and sustainability businesses. Its healthcare portfolio has included companies spanning medical devices, therapeutics, diagnostics, cell and regenerative medicine, and biotech-enabling technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brightlands Venture Partners.